×
+ All Categories
Log in
English
Français
Español
Deutsch
Report -
A Phase 1b/2, Multicenter, Open-Label, Safety, and Dose-Finding … · 2020-01-15 · Alexion Pharmaceuticals Inc. Protocol SYNT001-103 CONFIDENTIAL V1.0 March 25, 2019 Page 1 of
Name
Email
Select
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Message
Please pass captcha verification before submit form